SCOPUS 정보 검색 플랫폼

Volumn 35, Issue 4, 2002, Pages 930-936

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

(7) Buti, Maria a Sanchez Avila, Francisco a Lurie, Yoav b Stalgis, Carlos c Valds, Auristela a Martell, Maria a Esteban, Rafael a

a HOSPITAL UNIVERSITARI VALL D HEBRON (Spain)

b Gastroenterology Institute (Israel)

c MERCK RESEARCH LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIDE EFFECT; VIRUS LOAD;

EID: 0036208536 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2002.32150 Document Type: Article

Times cited : (106)

References (22)

1
- 0034324083
- Pegylated interferon-α-2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
- (2000) Clin Pharmacol Ther , vol.68 , pp. 556-567
- Glue, P.¹ Fang, J.W.S.² Rouzier-Panis, R.³ Raffanel, C.⁴ Sabo, R.⁵ Gupta, S.K.⁶ Salfi, M.⁷

2
- 0001173731
- Phase I study of polyethylene glycol (PEG) interferon alpha-2b (Intron A) in CML patients
- (1998) Blood , vol.92 , pp. 251A
- Talpaz, M.¹ Cortes, J.² O'Brien, S.³ Keating, M.⁴ Giles, F.⁵ Rose, E.⁶ Rybak, M.E.⁷

3
- 0033844251
- A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 647-653
- Glue, P.¹ Rouzier-Panis, R.² Raffanel, C.³ Sabo, R.⁴ Gupta, S.K.⁵ Salfi, M.⁶ Jacobs, S.⁷

4
- 17844403232
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
- (2001) Hepatology , vol.34 , pp. 395-403
- Lindsay, K.L.¹ Trepo, C.² Heintges, T.³ Schiffman, M.⁴ Gordon, S.⁵ Hoefs, J.⁶ Schiff, E.⁷

5
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³ Heathcote, E.J.⁴ Lai, M.-Y.⁵ Gane, E.⁶ O'Grady, J.⁷

6
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.D.⁷

7
- 0032585237
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷

8
- 0033054813
- EASL International Consensus Conference on Hepatitis C: Paris, 26-28 February 1999. Consensus statement
- (1999) J Hepatol , vol.30 , pp. 956-961

9
- 0035934568
- Peginterferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: Results of a randomised trial
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³ Rustgi, V.K.⁴ Shiffman, M.⁵ Reindollar, R.⁶ Goodman, Z.D.⁷

10
- 0000474902
- Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2b plus ribavirin
- (2000) Hepatology , vol.32 , pp. 317A
- Carithers, R.L.¹ Zeuzem, S.² Manns, M.P.³ McHutchison, J.G.⁴ Perrillo, R.P.⁵ Bailey, R.⁶ Ling, M.-H.⁷

11
- 0345355151
- High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA
- (1999) J Clin Microbiol , vol.37 , pp. 327-332
- Martell, M.¹ Gómez, J.² Esteban, J.I.³ Sauleda, S.⁴ Quer, J.⁵ Cabot, B.⁶ Esteban, R.⁷

12
- 0031009603
- Dose-dependent acute clearance of Hepatitis C genotype 1 virus with interferon alfa
- (1997) Hepatology , vol.26 , pp. 226-231
- Lam, N.P.¹ Neumann, A.U.² Gretch, D.R.³ Wiley, T.E.⁴ Perelson, A.S.⁵ Layden, T.J.⁶

13
- 0031924165
- Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
- (1998) Hepatology , vol.27 , pp. 1149-1156
- Zeuzem, S.¹ Lee, J.-H.² Franke, A.³ Rüster, B.⁴ Prümmer, O.⁵ Herrmann, G.⁶ Roth, W.K.⁷

14
- 0032102892
- Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy
- (1998) J Hepatol , vol.28 , pp. 960-964
- Bekkering, F.C.¹ Brouwer, J.T.² Leroux-Roels, G.³ Van Vlierberghe, H.⁴ Elewaut, A.⁵ Schalm, S.W.⁶

15
- 0031807791
- Hepatitis C dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
- (1998) Hepatology , vol.28 , pp. 245-252
- Zeuzem, S.¹ Schmidt, J.M.² Lee, J.H.³ Von Wagner, M.⁴ Teuber, G.⁵ Roth, W.K.⁶

16
- 0033404706
- Clinical implications of hepatitis C viral kinetics
- (1999) J Hepatol , vol.31 , pp. 61-64
- Zeuzem, S.¹

17
- 0033392035
- Principles of interferon induction therapy
- (1999) Am J Med , vol.107 , pp. 71S-73S
- Layden, T.J.¹

18
- 0032475822
- Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
- (1998) Science , vol.282 , pp. 103-107
- Neumann, A.U.¹ Lam, N.P.² Dahari, H.³ Gretch, D.R.⁴ Wiley, T.E.⁵ Layden, T.J.⁶ Perelson, A.S.⁷

19
- 0035140876
- Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model
- (2001) Hepatology , vol.33 , pp. 419-423
- Bekkering, F.C.¹ Stalgis, C.² McHutchison, J.G.³ Brouwer, J.T.⁴ Perelson, A.S.⁵

20
- 4243406137
- Assesment of optimal dosing frequency of pegylated interferon alfa-2b (Pegintrom) in chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 1138A
- Lurie, Y.¹ Dusheiko, G.² Rouzier-Panis, R.³ Glue, P.⁴

21
- 0035050182
- Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
- (2001) Gastroenterology , vol.120 , pp. 1438-1447
- Zeuzem, S.¹ Herrmann, E.² Lee, J.-H.³ Fricke, J.⁴ Neumann, A.U.⁵ Modi, M.⁶ Colucci, G.⁷

22
- 0033965331
- Is "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
- (2000) Hepatology , vol.31 , pp. 211-218
- Poynard, T.¹ McHutchison, J.² Goodman, Z.³ Ling, A.H.⁴ Albrecht, J.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.